Your session is about to expire
Pantoprazole vs Omeprazole
Introduction
For patients suffering from gastroesophageal reflux disease (GERD) or other types of stomach acid-related issues, certain drugs that reduce the production of gastric acid in the stomach can help in relieving symptoms and preventing damage to the esophagus. Pantoprazole and Omeprazole are two such medications often prescribed for these conditions. Both are proton pump inhibitors (PPIs), which work by blocking an enzyme in the stomach lining responsible for producing acid. Pantoprazole is known to have a longer duration of action compared to Omeprazole, meaning it may provide relief for a more extended period. On the other hand, Omeprazole is available over-the-counter without needing a prescription from a healthcare provider, making it accessible for immediate symptom relief.
Pantoprazole vs Omeprazole Side By Side
| Attribute | Protonix | Prilosec |
|---|---|---|
| Brand Name | Protonix | Prilosec |
| Contraindications | Should not be used with the HIV medication Atazanavir. Long-term use associated with vitamin B-12 deficiency. | Should not be used with the HIV medication Atazanavir. Long-term use associated with vitamin B-12 deficiency. |
| Cost | For brand name, around $260 for 30 tablets (40 mg). For generic, as low as $0.25/day. | For brand name, about $240 for 30 capsules (20 mg). For generic, starts at pennies per day. |
| Generic Name | Pantoprazole | Omeprazole |
| Most Serious Side Effect | Severe skin reactions, lupus-like syndrome, kidney problems, symptoms of low magnesium levels. | Allergic reactions, new or worsening joint pain, skin rash worsened by sunlight, rapid heartbeats, jerking muscle movements. |
| Severe Drug Interactions | Can interact with medications metabolized through the CYP2C19 pathway. | Not specified, but similar to Pantoprazole due to both being PPIs and affecting stomach acid production. |
| Typical Dose | 20-40 mg/day, up to a maximum of 80 mg/day for adults. | 20 mg/day, can be increased to 40 mg/day, with a maximum of 80 mg/day. |
What is Pantoprazole?
Pantoprazole (known by the brand name Protonix) and Omeprazole (Prilosec) are both classified as proton pump inhibitors, a type of medication that reduces acid production in the stomach. This class of drugs is typically used to treat conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Pantoprazole received FDA approval in 2000 while omeprazole got its approval earlier in 1989. Both medications work by blocking the enzyme in your stomach wall responsible for producing acid, thereby reducing the amount of gastric acidity. They are prescribed for similar uses; however, their effects can be experienced differently based on individual cases. While pantoprazole has been found to have longer-lasting effects compared to omeprazole, it may also cause fewer side effects due to its more selective action within the body's cells.
What conditions is Pantoprazole approved to treat?
Pantoprazole is approved for the treatment of several conditions related to the excessive production of stomach acid:
- Gastroesophageal reflux disease (GERD)
- Erosive esophagitis
- Zollinger-Ellison syndrome
- Other pathological hypersecretory conditions.
For Helicobacter pylori eradication, it can be used in combination with appropriate antibiotic therapy.
How does Pantoprazole help with these illnesses?
Pantoprazole works to manage acid-related disorders by reducing the amount of gastric acid produced in the stomach. It does this by inhibiting a type of cell, known as a proton pump, from releasing hydrogen ions into the stomach. Hydrogen ions are fundamental in forming gastric acid which contributes to conditions such as gastroesophageal reflux disease (GERD), peptic ulcers and Zollinger-Ellison syndrome.
Gastric acid is necessary for digestion but too much can lead to inflammation and discomfort. Pantoprazole helps limit these negative effects by decreasing gastric acidity and providing relief from symptoms like heartburn or difficulty swallowing. Like Prozac increases serotonin levels, Pantoprazole reduces hydrogen ion release - both helping patients manage their condition more efficiently.
What is Omeprazole?
Omeprazole, marketed under the brand name Prilosec among others, is a proton pump inhibitor (PPI). This means it works by reducing the amount of acid your stomach produces. Omeprazole was first approved by the FDA in 1989. As omeprazole is not an H2 blocker, it does not act on histamine receptors to suppress stomach acid production. This difference in mechanism of action means that its side-effect profile is also different from that of H2 blockers, specifically in that it does not cause the common side effects of H2 blockers such as headache, dizziness, and diarrhea. The effect of omeprazole on gastric acid secretion can be beneficial in the treatment of acid-related disorders, especially in patients who do not respond well to the "typical" H2 blocker medications. The efficacy of omeprazole has made it a first-line treatment option for conditions such as gastroesophageal reflux disease (GERD) and peptic ulcer disease.
What conditions is Omeprazole approved to treat?
Omeprazole is an FDA-approved proton pump inhibitor intended for the treatment of various conditions related to excessive stomach acid. These include:
- Gastroesophageal reflux disease (GERD)
- Erosive esophagitis
- Duodenal and gastric ulcers
- Zollinger-Ellison syndrome, a rare condition where the stomach produces too much acid
How does Omeprazole help with these illnesses?
Omeprazole is a proton pump inhibitor (PPI) that works by reducing the production of stomach acid, therefore providing relief from conditions such as gastroesophageal reflux disease (GERD), ulcers, and heartburn. Omeprazole effectively blocks an enzyme in the lining of the stomach involved in producing acid, thereby decreasing the acidity and volume of gastric juices. This action can also promote healing of erosive esophagitis (damage to your esophagus caused by stomach acid). While Pantoprazole operates in a similar way to reduce stomach acid, Omeprazole may be preferred for its longer duration of effect or its wider accessibility since it's available over-the-counter unlike Pantoprazole which typically requires prescription. However, like any medication choice, individual patient needs and responses should be considered.
How effective are both Pantoprazole and Omeprazole?
Both pantoprazole and omeprazole are proton pump inhibitors (PPIs) with well-established track records in managing gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related disorders. Approved by the FDA within a few years of each other, they act on the same enzyme system to reduce gastric acid production but may be prescribed under slightly different circumstances due to their pharmacokinetics.
In 2000, a double-blind clinical trial directly compared pantoprazole and omeprazole in treating erosive esophagitis; both drugs demonstrated comparable efficacy in healing and symptom relief along with similar safety profiles. None of the metrics used to measure effectiveness—in this case, endoscopic healing rates—differed significantly between patients receiving pantoprazole or those given omeprazole.
A review study conducted in 2005 reported that both pantoprazole and omeprazole effectively manage symptoms associated with GERD starting from the first week of treatment. Their side effect profiles were considered favorable compared many other agents for acid suppression therapy, making them well-tolerated even among elderly populations or individuals who require chronic use.
Another review published in 2016 indicated that while both PPIs show robust efficacy against placebo when it comes to relieving GERD symptoms or promoting ulcer healing, there is no clear-cut superiority between them regarding therapeutic outcomes. However, some evidence suggests that Pantoprazole might be less likely than Omeprazole to interact with other medications metabolized through the CYP2C19 pathway because of its weaker inhibitory effects on this metabolic route. This difference could make Pantoprazole a more optimal choice for patients taking certain concurrent medications.
Related trials for pantoprazole and omeprazole
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Pantoprazole typically prescribed?
Oral dosages of Pantoprazole range from 20-40 mg/day, with studies indicating that a daily dose of 40 mg is sufficient for treating gastroesophageal reflux disease (GERD) in most adults. For children aged 5 years and above, the starting dosage can be as low as 20 mg/day depending on their weight. If there's no response after a few weeks, the dosage may be increased under medical supervision. However, the maximum dosage that should not be exceeded in any case is 80 mg/day for adults and varies based on weight for children.
At what dose is Omeprazole typically prescribed?
Treatment with Omeprazole typically begins at a dosage of 20 mg/day. The dose can then be increased to 40 mg/day, divided into two doses and spaced out by approximately 12 hours. A maximum dose of 80 mg/day, divided into two doses of 40mg and taken roughly every twelve hours, may be considered if there is no response to the treatment at the initial dose after several weeks. As always, it is crucial that you follow your healthcare provider's instructions when taking any medication.
What are the most common side effects for Pantoprazole?
Common side effects of both Pantoprazole and Omeprazole include:
- Headache
- Diarrhea, nausea, vomiting, stomach pain
- Gas and bloating
- Dizziness, fatigue or weakness
- Joint pain
- Dry mouth or throat discomfort
More serious but less common side effects may include rapid heart rate, muscle spasms, seizures, depression symptoms (mood changes), and lupus-like syndrome. If you experience any unusual symptoms while taking these medications seek medical assistance immediately. It's important to remember that each individual might react differently to the medication; hence it is crucial to consult with your healthcare provider for personalized advice.
Are there any potential serious side effects for Pantoprazole?
While unusual, Pantoprazole can cause severe side effects in certain circumstances. If you experience any of the following symptoms while taking this medication, seek emergency medical help right away:
- Signs of an allergic reaction such as difficulty breathing, swelling in your face or throat, hives
- Serious skin reactions like blisters and peeling rash accompanied by fever and burning eyes
- Symptoms associated with low magnesium levels - dizziness, fast or irregular heartbeat, jitteriness; muscle cramps or weakness; seizures (convulsions); feeling jittery; shakiness (tremors)
- Lupus-like syndrome which includes joint pain or swelling with fever coupled with muscle aches
- Kidney problems: urinating less than usual or not at all; blood in your urine; severe lower back pain; Symptoms related to Vitamin B12 deficiency: pale skin, feeling tired or shortness of breath
Remember that it's important to take pantoprazole only as directed by a healthcare professional. If you experience any unusual health changes while on this medication – whether listed above or not – contact your doctor promptly.
What are the most common side effects for Omeprazole?
Common side effects of Omeprazole can potentially include:
- Headache and dizziness
- Diarrhea, constipation, stomach pain
- Nausea or vomiting
- Gas
- Rash or itchy skin
- Sleep problems such as insomnia
- Muscle weakness or joint pain. It is important to note that not everyone who takes Omeprazole experiences these side effects. If you have persistent or concerning symptoms while taking this medication, please consult with your healthcare provider.
Are there any potential serious side effects for Omeprazole?
While Omeprazole is generally well-tolerated, it can cause serious side effects in some instances. If you experience any of the following symptoms while taking Omeprazole, seek immediate medical attention:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling of your face, lips, tongue, or throat
- New or worsening joint pain
- A skin rash on your cheeks or arms that worsens in sunlight
- Rapid heartbeats
- Jerking muscle movements
- Dizziness (like you might pass out)
- Diarrhea that is watery or bloody
It's also important to monitor for changes in urination patterns and urine color, which could be indicative of kidney problems. Additionally, sudden weight gain may signal liver issues. Always contact a healthcare professional if these symptoms arise.
Contraindications for Pantoprazole and Omeprazole?
Both Pantoprazole and Omeprazole, as with most proton pump inhibitors (PPIs), may lead to certain uncomfortable symptoms or side effects in some people. If you notice an increase in severe stomach pain, irregular heartbeat, persistent muscle spasms, seizures or unusual changes in mood such as confusion and nervousness while taking these medications, please seek immediate medical attention.
Neither Pantoprazole nor Omeprazole should be used if you are taking the HIV medication Atazanavir. Always inform your doctor about all the medications you are currently taking; this includes prescriptions drugs, over-the-counter products and even herbal supplements. Certain drugs require a specific amount of stomach acid for absorption so PPIs may impact the effectiveness of these drugs.
Long-term use of both Pantoprazole and Omeprazole has been associated with vitamin B-12 deficiency due to decreased absorption from food caused by reduced stomach acidity. Therefore it's important to monitor your health regularly when using these medications for prolonged periods.
How much do Pantoprazole and Omeprazole cost?
For the brand name versions of these drugs:
- The price for 30 tablets of Protonix (pantoprazole, 40 mg) averages around $260, which works out to approximately $8.70/day.
- The price for 30 capsules of Prilosec (omeprazole, 20 mg) is about $240 on average, working out to roughly $8 per day.
Thus, if you're given a typical dose regimen for either pantoprazole or omeprazole (usually once daily), then brand-name Prilosec tends to be slightly less expensive on a per-day treatment basis. However, it's important to remember that cost should not be the primary consideration when deciding which medication is right for you.
For generic versions of pantoprazole and omeprazole:
- Pantoprazole (40 mg tablets) is available in packs of 30 tablets and up with approximate costs from as low as $0.25/day for a usual dosage regimen.
- Omeprazole comes in packs ranging from 10 up to hundreds capsules/tablets (20 mg), with your cost starting at mere pennies per day if bought in larger quantities upfront.
Popularity of Pantoprazole and Omeprazole
Pantoprazole, commonly known as brand names such as Protonix, was prescribed to an estimated 14.6 million people in the US in 2019. This accounted for just over 15% of proton pump inhibitor (PPI) prescriptions in the USA that year. Pantoprazole has been widely used due to its effectiveness and tolerability since it came into use.
Omeprazole, including well-known brands like Prilosec, was prescribed to around 20.4 million people in the USA during the same period. In terms of PPI usage across America, omeprazole carries a larger market share with almost 22% of all PPI prescriptions written being for this medication. Omeprazole's popularity is likely due to its established efficacy and affordability given its availability both via prescription and over-the-counter options.
Both these drugs are powerful tools against conditions caused by excess stomach acid production like gastroesophageal reflux disease (GERD), ulcers among others but they differ slightly in their pharmacokinetics which can influence individual patient response.
Conclusion
Both Pantoprazole and Omeprazole have established records of usage in patients suffering from conditions associated with excess stomach acid, such as gastroesophageal reflux disease (GERD), ulcers, and Zollinger-Ellison syndrome. Their efficacy is backed by numerous clinical trials demonstrating they are more effective than placebo treatments. They both belong to the proton pump inhibitor (PPI) class of drugs which function by reducing the production of gastric acid.
The choice between pantoprazole and omeprazole may depend on individual patient factors, as well as physician preference. Both PPIs can be used alone or sometimes in combination with other medications for specific indications.
Both drugs are available in generic form, making them relatively affordable options for most patients. It's worth noting that it can take a few days before their effects become noticeable since they do not provide immediate relief like antacids.
Side effect profiles for pantoprazole and omeprazole are similar; common side effects include headache, diarrhea, nausea, vomiting, flatulence and stomach pain. Long-term use has been associated with an increased risk of bone fractures , kidney problems,and vitamin B12 deficiency among others. For both medications patients should monitor how they feel after starting treatment and seek medical attention if any severe or unexpected symptoms occur.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- CORINALDESI, R., VALENTINI, M., BELAÏCHE, J., COLIN, R., GELDOF, H., MAIER, C., & THE EUROPEAN PANTOPRAZOLE STUDY GROUP. (1995, December). Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study. Alimentary Pharmacology & Therapeutics. Wiley.http://doi.org/10.1111/j.1365-2036.1995.tb00437.x
- Mcarthur, K. E., Collen, M. J., Maron, P. N., Cherner, J. A., Howard, J. M., Ciarleglio, C. A., … Gardner, J. D. (1985, April). Omeprazole: Effective, Convenient Therapy for Zollinger—Ellison Syndrome. Gastroenterology. Elsevier BV.http://doi.org/10.1016/s0016-5085(85)80011-1
- Cheer, S. M., Prakash, A., Faulds, D., & Lamb, H. M. (2003). Pantoprazole. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200363010-00006
- Robinson, M., & Horn, J. (2003). Clinical Pharmacology of Proton Pump Inhibitors. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200363240-00004
- Reilly, J. P. (1999, December 1). Safety profile of the proton-pump inhibitors. American Journal of Health-System Pharmacy. Oxford University Press (OUP).http://doi.org/10.1093/ajhp/56.suppl_4.s11
- Mouly, S., Charlemagne, A., Lejeunne, P., & Fagnani, F. (2009, August). Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitution. Current Therapeutic Research. Elsevier BV.http://doi.org/10.1016/j.curtheres.2009.07.001
- Huang, J.-Q., & Hunt, R. H. (2001, June). Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician. Best Practice & Research Clinical Gastroenterology. Elsevier BV.http://doi.org/10.1053/bega.2001.0184
- Van Rensburg, C., Honiball, P., Grundling, H., Van Zyl, J., Spies, S., Eloff, F., … Bethke, T. (1996, June). Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis. Alimentary Pharmacology & Therapeutics. Wiley.http://doi.org/10.1111/j.0953-0673.1996.00397.x
- Kita, T., Sakaeda, T., Aoyama, N., Sakai, T., Kawahara, Y., Kasuga, M., & Okumura, K. (2002). Optimal Dose of Omeprazole for CYP2C19 Extensive Metabolizers in Anti-Helicobacter pylori Therapy: Pharmacokinetic Considerations. Biological and Pharmaceutical Bulletin. Pharmaceutical Society of Japan.http://doi.org/10.1248/bpb.25.923
- Gupta, P. P., Bhandari, R., Mishra, D. R., Agrawal, K. K., Bhandari, R., Jirel, S., & Malla, G. (2018, May). Anaphylactic reactions due to pantoprazole: case report of two cases. International Medical Case Reports Journal. Informa UK Limited.http://doi.org/10.2147/imcrj.s153099
- Thomson, A. B. R. (2000, November). Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole. Current Gastroenterology Reports. Springer Science and Business Media LLC.http://doi.org/10.1007/s11894-000-0013-0
- McArthur, K. E., Jensen, R. T., & Gardner, J. D. (1986, February). Treatment of Acid-Peptic Diseases by Inhibition of Gastric H+,K+_Atpase. Annual Review of Medicine. Annual Reviews.http://doi.org/10.1146/annurev.me.37.020186.000525